Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal inflammatory status and epidural-related maternal fever trial
ChiCTR1900023966Phase 4Not yet recruiting
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in fever and labor pain (3 arms), sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoints: Ear temperature, Blood interleukin-6 and 2 more. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
feverlabor pain
Beyond the preview
Go deeper on ChiCTR1900023966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023966.